RISK MODIFICATION OF TUBERCULOSIS INFECTION BY CHEMOPROPHYLAXIS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TNF INHIBITORS: A NATION-WIDE COHORT STUDY

被引:0
|
作者
Shin, A. [1 ]
Park, E. H. [1 ]
Ha, Y. J. [1 ]
Lee, Y. J. [1 ]
Song, Y. W. [2 ]
Kang, E. H. [1 ]
机构
[1] Seoul Natl Univ Bundang Hosp, Seongnam, South Korea
[2] Seoul Natl Univ Hosp, Seoul, South Korea
关键词
LATENT TUBERCULOSIS;
D O I
10.1136/annrheumdis-2020-eular.2072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THU0180
引用
收藏
页码:303 / 304
页数:2
相关论文
共 50 条
  • [31] Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study
    Kang, Eun Ha
    Choi, Hyon K.
    Shin, Anna
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong Wook
    Kim, Seoyoung C.
    [J]. RHEUMATOLOGY, 2019, 58 (12) : 2122 - 2129
  • [32] Risk and Outcome of Venous and Arterial Thrombosis in Patients With Cirrhosis: A Danish Nation-wide Cohort Study
    Jepsen, Peter
    Tapper, Elliot B.
    Deleuran, Thomas
    Kazankov, Konstantin
    Askgaard, Gro
    Sorensen, Henrik Toft
    Vilstrup, Hendrik
    West, Joe
    [J]. HEPATOLOGY, 2021, 74 (05) : 2725 - 2734
  • [33] Colorectal cancer risk in adenoma patients: A nation-wide study
    Loeve, F
    van Ballegooijen, M
    Boer, R
    Kuipers, EJ
    Habbema, JDF
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (01) : 147 - 151
  • [34] Tuberculosis chemoprophylaxis in rheumatoid arthritic patients receiving tumor necrosis factor inhibitors or conventional therapy
    Samra, Saad Rabie
    Habeeb, Mohammad
    Halim, Ashraf Abdel
    Shebl, Eman
    [J]. EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2015, 64 (01): : 109 - 113
  • [35] OVERALL INFECTION RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ABATACEPT, RITUXIMAB AND TOCILIZUMAB. AN OBSERVATIONAL COHORT STUDY
    Gron, Kathrine
    Glintborg, Bente
    Mehnert, Frank
    Ostergaard, Mikkel
    Dreyer, Lene
    Norgaard, Mette
    Krogh, Niels Steen
    Hetland, Merete L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 630 - 630
  • [36] Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol
    Alina Soare
    Ana Maria Gheorghiu
    Victoria Aramă
    Dragoș Bumbăcea
    Rucsandra Dobrotă
    Raida Oneaţă
    Simona Pintilie
    Mihaela Milicescu
    Ioan Ancuţa
    Andrei Martin
    Mariana Sasu
    Claudia Ciofu
    Liviu Macovei
    Victor Stoica
    Mihai Bojincă
    Carina Mihai
    [J]. Clinical Rheumatology, 2018, 37 : 2391 - 2397
  • [37] Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocol
    Soare, Alina
    Gheorghiu, Ana Maria
    Arama, Victoria
    Bumbacea, Dragos
    Dobrota, Rucsandra
    Oneata, Raida
    Pintilie, Simona
    Milicescu, Mihaela
    Ancuta, Ioan
    Martin, Andrei
    Sasu, Mariana
    Ciofu, Claudia
    Macovei, Liviu
    Stoica, Victor
    Bojinca, Mihai
    Mihai, Carina
    [J]. CLINICAL RHEUMATOLOGY, 2018, 37 (09) : 2391 - 2397
  • [38] Diabetes Is Associated with Higher Risk of Accidents-A Nation-wide Cohort Study
    West, Caecilie
    Gislason, Gunnar H.
    Nume, Anna-Karin
    Vilsboll, Tina
    Torp-Pedersen, Christian
    Jensen, Magnus T.
    [J]. DIABETES, 2015, 64 : A104 - A105
  • [39] ACTIVE TUBERCULOSIS IN ARTHRITIS PATIENTS RECEIVING TNF INHIBITORS DESPITE BASELINE SCREENING
    Soare, A.
    Gherghe, A. M.
    Dobrota, R.
    Pintilie, S.
    Oneata, R.
    Ancuta, I.
    Milicescu, M.
    Martin, A.
    Sasu, M.
    Ciofu, C.
    Macovei, L.
    Stoica, V.
    Bojinca, M.
    Mihai, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 778 - 779
  • [40] ACUTE CARDIOVASCULAR EVENTS RISK IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB OR TNF INHIBITORS, A NATIONWIDE COHORT STUDY: RELATION STUDY
    Gottenberg, J. E.
    Kessouri, M.
    Rudant, J.
    Assi, N.
    Grenier, B.
    Kirchgesner, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 402 - 402